The emerging role of long non-coding RNAs in the drug resistance of colorectal cancer

被引:2
作者
Chen, Dong-Liang [1 ]
Xu, Rui-Hua [1 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, 651 Dong Feng East Rd, Guangzhou, Guangdong, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2018年 / 11卷 / 10期
基金
中国国家自然科学基金;
关键词
CRC; lncRNA; drug resistance; OXALIPLATIN-BASED CHEMOTHERAPY; MOLECULAR-MECHANISMS; METASTATIC PROGRESSION; CISPLATIN RESISTANCE; MULTIDRUG-RESISTANCE; DECREASED EXPRESSION; SIGNALING PATHWAY; DOWN-REGULATION; CETUXIMAB; FLUOROURACIL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer (CRC) remains one of the leading causes of cancer-related deaths in the world. Chemotherapy has been used to treat CRC patients in order to improve prognosis. Oxaliplatin and 5-Fluorouracil (5-FU) based chemotherapy is a first line treatment for locally advanced and metastatic CRC. For patients with wild-type KRAS metastatic CRC, cetuximab (an EGFR monoclonal antibody) is a commonly used targeted therapy. CRC is initially sensitive to chemotherapy and targeted therapy. However, drug resistance frequently arises, which significantly affect the treatment outcome in these patients. An increasing number of studies have indicated that lncRNAs are implicated in the drug resistance of CRC. This review aims to gain insights into the role and molecular mechanism of lncRNAs in CRC drug resistance.
引用
收藏
页码:4735 / 4743
页数:9
相关论文
共 70 条
[1]  
Abolhoda A, 1999, CLIN CANCER RES, V5, P3352
[2]   Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group Phase II study [J].
Alberts, SR ;
Horvath, WL ;
Stcrnfeld, WC ;
Goldberg, RM ;
Mahoney, MR ;
Dakhil, SR ;
Levitt, R ;
Rowland, K ;
Nair, S ;
Sargent, DJ ;
Donohue, JH .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9243-9249
[3]   Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies [J].
Benvenuti, Silvia ;
Sartore-Bianchi, Andrea ;
Di Nicolantonio, Federica ;
Zanon, Carlo ;
Moroni, Mauro ;
Veronese, Silvio ;
Siena, Salvatore ;
Bardelli, Alberto .
CANCER RESEARCH, 2007, 67 (06) :2643-2648
[4]   LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p [J].
Bian, Zehua ;
Jin, Liugen ;
Zhang, Jiwei ;
Yin, Yuan ;
Quan, Chao ;
Hu, Yaling ;
Feng, Yuyang ;
Liu, Heyong ;
Fei, Bojian ;
Mao, Yong ;
Zhou, Leyuan ;
Qi, Xiaowei ;
Huang, Shenlin ;
Hua, Dong ;
Xing, Chungen ;
Huang, Zhaohui .
SCIENTIFIC REPORTS, 2016, 6
[5]   Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression [J].
Chen, Dong-liang ;
Lu, Yun-xin ;
Zhang, Jia-xing ;
Wei, Xiao-li ;
Wang, Feng ;
Zeng, Zhao-lei ;
Pan, Zhi-zhong ;
Yuan, Yun-fei ;
Wang, Feng-hua ;
Pelicano, Helene ;
Chiao, Paul J. ;
Huang, Peng ;
Xie, Dan ;
Li, Yu-hong ;
Ju, Huai-qiang ;
Xu, Rui-hua .
THERANOSTICS, 2017, 7 (19) :4836-4849
[6]   Long noncoding RNA XIST expedites metastasis and modulates epithelial-mesenchymal transition in colorectal cancer [J].
Chen, Dong-liang ;
Chen, Le-zong ;
Lu, Yun-xin ;
Zhang, Dong-sheng ;
Zeng, Zhao-lei ;
Pan, Zhi-zhong ;
Huang, Peng ;
Wang, Feng-hua ;
Li, Yu-hong ;
Ju, Huai-qiang ;
Xu, Rui-hua .
CELL DEATH & DISEASE, 2017, 8 :e3011-e3011
[7]   Insulin caused drug resistance to oxaliplatin in colon cancer cell line HT29 [J].
Chen, Jiezhong ;
Huang, Xu-Feng ;
Qiao, Liang ;
Katsifis, Andrew .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2011, 2 (01) :27-33
[8]   H19 Overexpression Induces Resistance to 1,25(OH) 2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells [J].
Chen, Shanwen ;
Bu, Dingfang ;
Ma, Yuanyuan ;
Zhu, Jing ;
Chen, Guowei ;
Sun, Lie ;
Zuo, Shuai ;
Li, Tengyu ;
Pan, Yisheng ;
Wang, Xin ;
Liu, Yucun ;
Wang, Pengyuan .
NEOPLASIA, 2017, 19 (03) :226-236
[9]   ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy [J].
Cui, Haigang ;
Zhang, Anna J. ;
Chen, Mingwei ;
Liu, Johnson J. .
CURRENT DRUG TARGETS, 2015, 16 (12) :1356-1371
[10]   SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization [J].
Damas, Nkerorema Djodji ;
Marcatti, Michela ;
Come, Christophe ;
Christensen, Lise Lotte ;
Nielsen, Morten Muhlig ;
Baumgartner, Roland ;
Gylling, Helene Maria ;
Maglieri, Giulia ;
Rundsten, Carsten Friis ;
Seemann, Stefan E. ;
Rapin, Nicolas ;
Thezenas, Simon ;
Vang, Soren ;
Orntoft, Torben ;
Andersen, Claus Lindbjerg ;
Pedersen, Jakob Skou ;
Lund, Anders H. .
NATURE COMMUNICATIONS, 2016, 7